{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:38:38Z","timestamp":1772206718513,"version":"3.50.1"},"reference-count":29,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/etm.2016.3681","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T04:53:16Z","timestamp":1473223996000},"page":"2617-2621","source":"Crossref","is-referenced-by-count":15,"title":["Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion"],"prefix":"10.3892","volume":"12","author":[{"given":"Xiao-Jun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"key20180108132548_b1-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"374616","DOI":"10.1155\/2015\/374616","article-title":"Atrial fibrillation and coronary artery disease as risk factors of retinal artery occlusion: a nationwide population-based study","volume":"2015","author":"Yen","year":"2015","journal-title":"BioMed Res Int"},{"key":"key20180108132548_b2-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jfo.2015.04.016","article-title":"Idiopathic central retinal artery occlusion in an eight-year-old girl","volume":"39","author":"Antoun","year":"2016","journal-title":"J Fr Ophtalmol"},{"key":"key20180108132548_b3-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.STR.31.4.841","article-title":"Treatment of intraventricular hemorrhage with urokinase : Effects on 30-Day survival","volume":"31","author":"Naff","year":"2000","journal-title":"Stroke"},{"key":"key20180108132548_b4-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"key":"key20180108132548_b5-etm-0-0-3681","first-page":"1301","article-title":"Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment","volume":"23","author":"Schmidt","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"key20180108132548_b6-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","article-title":"Central retinal artery occlusion: visual outcome","volume":"140","author":"Hayreh","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key20180108132548_b7-etm-0-0-3681","first-page":"CD000213","article-title":"Thrombolysis for acute ischaemic stroke","volume":"7","author":"Wardlaw","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180108132548_b8-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.011","article-title":"Intravenous tissue plasminogen activator therapy for an acute ischemic stroke patient with later diagnosed unilateral moyamoya syndrome","volume":"22","author":"Yokoyama","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key20180108132548_b9-etm-0-0-3681","first-page":"2775","article-title":"Myocardial infarction following recombinant tissue plasminogen activator treatment for acute ischemic stroke: a dangerous complication","volume":"125","author":"Zhou","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"key20180108132548_b10-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key20180108132548_b11-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","article-title":"Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"key20180108132548_b12-etm-0-0-3681","first-page":"1234","article-title":"Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion","volume":"120","author":"Kattah","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key20180108132548_b13-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"913.e5","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.01.003","article-title":"Acute central retinal artery occlusion treated with intravenous recombinant tissue plasminogen activator","volume":"21","author":"Nowak","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key20180108132548_b14-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/ICU.0b013e328329b5d5","article-title":"Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?","volume":"20","author":"Hazin","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"key20180108132548_b15-etm-0-0-3681","first-page":"245","article-title":"Thrombolysis in central retinal artery occlusion using alteplase","volume":"64","author":"Mach","year":"2008","journal-title":"Cesk Slov Oftalmol"},{"key":"key20180108132548_b16-etm-0-0-3681","first-page":"1","article-title":"Research progess on introducing thrombolytic therapy into treating retinal central artery occlusion","volume":"25","author":"Ma","year":"2001","journal-title":"Int Rev Opthalmology"},{"key":"key20180108132548_b17-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3174\/ajnr.A1012","article-title":"Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset","volume":"29","author":"Sugiura","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"key20180108132548_b18-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/SCS.0000000000002308","article-title":"Rhabdomyolysis presenting as orbital apex syndrome","volume":"27","author":"Wi","year":"2016","journal-title":"J Craniofac Surg"},{"key":"key20180108132548_b19-etm-0-0-3681","first-page":"40","article-title":"Central retinal artery occlusion after phacoemulsification under peribulbar anaesthesia: pathogenic hypothesis","volume":"91","author":"Rodr\u00edguez","year":"2016","journal-title":"Arch Soc Esp Oftalmol"},{"key":"key20180108132548_b20-etm-0-0-3681","article-title":"Embolic central retinal artery occlusion after subcutaneous auricular steroid injection","author":"Chavala","year":"2015","journal-title":"Lancet"},{"key":"key20180108132548_b21-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"e0142852","DOI":"10.1371\/journal.pone.0142852","article-title":"No-reflow phenomenon in central retinal artery occlusion: incidence, risk factors, and clinical implications","volume":"10","author":"Ahn","year":"2015","journal-title":"PLoS One"},{"key":"key20180108132548_b22-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4103\/0301-4738.169796","article-title":"Central retinal artery occlusion following orbital tumor resection: is rapid intervention effective?","volume":"63","author":"Rajabi","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"key20180108132548_b23-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12886-015-0126-8","article-title":"Central retinal artery occlusion associated with persistent truncus arteriosus and single atrium: a case report","volume":"15","author":"Lu","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"key20180108132548_b24-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/WNO.0000000000000308","article-title":"Should patients with acute central retinal artery occlusion be treated with intra-arterial t-PA?: Comment","volume":"35","author":"Miller","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"key20180108132548_b25-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ophtha.2015.05.018","article-title":"Central retinal artery occlusion in a 21-year-old boxer","volume":"122","author":"Beck","year":"2015","journal-title":"Ophthalmology"},{"key":"key20180108132548_b26-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3928\/23258160-20151027-12","article-title":"Optical coherence tomography angiography compared to fluorescein angiography in branch retinal artery occlusion","volume":"46","author":"de Castro-Abeger","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key20180108132548_b27-etm-0-0-3681","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12750","article-title":"Atypical central retinal artery occlusion: an uncommon cause of retinopathy and visual loss in dermatomyositis","author":"Sharma","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"key20180108132548_b28-etm-0-0-3681","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4103\/0366-6999.166043","article-title":"Neuroprotective effect of compound anisodine in a mouse model with chronic ocular hypertension","volume":"128","author":"Liu","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"key20180108132548_b29-etm-0-0-3681","first-page":"110","article-title":"[The changes of hemodynamics in ocular trauma and treatment with compound anisodine]","volume":"32","author":"Zhu","year":"1996","journal-title":"Zhonghua Yan Ke Za Zhi"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3681\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T18:24:28Z","timestamp":1515435868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,9,7]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/etm.2016.3681"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3681","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}